NP
NBO Pharma Inc.
SEC filingPharmaceuticals · Bedford, NY
Amount raised$7.6Msold at filing
Total offering$7.6M
Investors in the raise93count reported to the SEC
FiledJan 22, 2026first sale Jun 12, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Colin David FosterDirector
Fredric David PriceExecutive Officer, Director
Robert David FriedmanDirector
Bard David GeesamanDirector
Executive officers, directors and promoters as listed on the Form D.